Tradestie Institutional Equity Comparison Engine

NUTX vs EVEX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NUTX Overall Edge

NUTX Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nutex Health Inc. Common Stock (NUTX) driven by superior Valuation, Growth & Margin, Momentum & Technical while EVEX counters with relative strength in Options & Structure. Fundamentally, NUTX trades at 6.2x Forward P/E with 53.7% operating margin (-18.7% YoY revenue) versus EVEX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, NUTX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against EVEX sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner NUTX
NUTX 6.2x vs EVEX N/M Fwd P/E
Growth & Margin Winner NUTX
Op Margin 53.7% vs 0.0% ยท YoY -18.7% vs +0.0%
Momentum & Technical Winner NUTX
1Y +53.6% vs -59.1% ยท 52W Pos 58% vs 8%
Options & Structure Winner EVEX
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (50th %ile IV)
NUTX NASDAQ
Nutex Health Inc. Common Stock
Services-Business Services, Nec
$167.10
-3.78% 1D
Market Cap $1.2B
1M Return -10.21%
1Y Return +53.57%
Forward P/E 6.2x
Unified AI Score
51.7 / 100 HOLD
Tech 32.0 Fund 48.0 Flow 50.0 Mom 60.0
EVEX NYSE
Eve Holding, Inc.
Aircraft
$1.70
+2.41% 1D
Market Cap $597.7M
1M Return +4.94%
1Y Return -59.13%
Forward P/E N/M
Unified AI Score
41.3 / 100 SELL
Tech 20.0 Fund 45.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NUTX +53.57% EVEX -59.13% Spread: +112.7 pp (NUTX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NUTX TTM Op. Margin: 53.7% EVEX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NUTX vs EVEX. Trailing 12-month operating profitability (NUTX 53.7% vs EVEX 0.0%) and valuation multiples (NUTX 6.2x vs EVEX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NUTX (9) vs EVEX (1)
Institutional Metric NUTX EVEX Criterion Row Winner
Market Capitalization Scale $1.2B $597.7M Larger Scale NUTX
Trailing P/E Ratio Valuation 7.5x N/M Lower Multiple NUTX
Forward P/E Ratio Valuation 6.2x N/M Lower Multiple NUTX
Revenue Growth (YoY) Growth -18.7% +0.0% Higher Growth EVEX
Operating Margin (TTM) Profitability 53.7% 0.0% Higher Margin NUTX
Net Profit Margin Profitability 20.7% 0.0% Higher Margin NUTX
Return on Equity (ROE) Capital Efficiency 47.6% -300.9% Higher ROE NUTX
52-Week Range Position Momentum 58% ($84โ€“$226) 8% ($1โ€“$5) Stronger Trend NUTX
Beta / 30D Volatility Risk Regime 1.78ฮฒ ยท 86% Vol 2.71ฮฒ ยท 96% Vol Lower Realized Risk NUTX
Unified Institutional Score Composite Signal 51.7 / 100 (HOLD) 41.3 / 100 (SELL) Higher Composite NUTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NUTX vs EVEX Buy Guide
NUTX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NUTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EVEX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EVEX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NUTX nor EVEX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.